A Dietrich1. 1. Klinik u. Poliklinik für Visceral‑, Transplantations‑, Thorax- u. Gefäßchirurgie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland. arne.dietrich@medizin.uni-leipzig.de.
Abstract
BACKGROUND: Sleeve gastrectomy is currently the most frequently performed bariatric procedure worldwide; however, with respect to a certain need for revisional surgery (due to reflux disease or weight regain) there is an ongoing discussion about the value of sleeve gastrectomy in terms of a stand-alone procedure. OBJECTIVE: The aim of this article is to critically discuss whether sleeve gastrectomy can still be considered a stand-alone procedure. MATERIAL AND METHODS: The current literature was searched for results after sleeve gastrectomy and the recommendations regarding this procedure are discussed. RESULTS: Currently approximately 50% of primary bariatric procedures are sleeve gastrectomies, which has become a well-established stand-alone procedure. Sleeve gastrectomy leads to good mid-term results; however, the results of the Roux-en-Y gastric bypass are comparatively superior in terms of type 2 diabetes remission, control of preexisting or de novo reflux disease and weight loss. The mortality is comparable; however, the morbidity is lower after sleeve gastrectomy but there is a relevant rate of fistulas of the stapler suture. CONCLUSION: Patients considered for sleeve gastrectomy must be informed of the procedure-specific risks, including the unforeseeable need for revision or redo surgery firstly due to weight regain or failing to reach the individual therapy target and secondly for worsening of a preexisting or de novo reflux disease.
BACKGROUND: Sleeve gastrectomy is currently the most frequently performed bariatric procedure worldwide; however, with respect to a certain need for revisional surgery (due to reflux disease or weight regain) there is an ongoing discussion about the value of sleeve gastrectomy in terms of a stand-alone procedure. OBJECTIVE: The aim of this article is to critically discuss whether sleeve gastrectomy can still be considered a stand-alone procedure. MATERIAL AND METHODS: The current literature was searched for results after sleeve gastrectomy and the recommendations regarding this procedure are discussed. RESULTS: Currently approximately 50% of primary bariatric procedures are sleeve gastrectomies, which has become a well-established stand-alone procedure. Sleeve gastrectomy leads to good mid-term results; however, the results of the Roux-en-Y gastric bypass are comparatively superior in terms of type 2 diabetes remission, control of preexisting or de novo reflux disease and weight loss. The mortality is comparable; however, the morbidity is lower after sleeve gastrectomy but there is a relevant rate of fistulas of the stapler suture. CONCLUSION:Patients considered for sleeve gastrectomy must be informed of the procedure-specific risks, including the unforeseeable need for revision or redo surgery firstly due to weight regain or failing to reach the individual therapy target and secondly for worsening of a preexisting or de novo reflux disease.
Authors: Dana A Telem; Jon Gould; Carl Pesta; Kinga Powers; Saniea Majid; Jacob A Greenberg; Andre Teixeira; Lionel Brounts; Henry Lin; Eric DeMaria; Raul Rosenthal Journal: Surg Obes Relat Dis Date: 2017-01-24 Impact factor: 4.734
Authors: Elisenda Climent; David Benaiges; Juan Pedro-Botet; Albert Goday; Ivan Solà; José M Ramón; Juana A Flores-LE Roux; Miguel Á Checa Journal: Minerva Endocrinol Date: 2017-02-15 Impact factor: 2.184
Authors: Ralph Peterli; Bettina Karin Wölnerhanssen; Thomas Peters; Diana Vetter; Dino Kröll; Yves Borbély; Bernd Schultes; Christoph Beglinger; Jürgen Drewe; Marc Schiesser; Philipp Nett; Marco Bueter Journal: JAMA Date: 2018-01-16 Impact factor: 56.272